Repligen Corporation (NASDAQ:RGEN, “Repligen”), a life sciences company focused on bioprocessing technology leadership, has acquired privately held Tantti Laboratory Inc. (“Tantti”) of Taoyuan City, Taiwan. Tantti has developed a unique portfolio of macroporous...
FlexBiosys Inc. (“FlexBiosys”), a designer and manufacturer of single-use bioprocessing bags and assemblies, has been sold to Repligen Corporation (“Repligen”). FlexBiosys is a US-based designer and manufacturer of single-use bioprocessing bags and assemblies....
Avitide Inc. (“Avitide”) a US-based pioneer in the development of proprietary affinity purification solutions, has been sold to Repligen Corporation (“Repligen”). The acquisition will strengthen Repligen’s Proteins business and move Repligen into affinity resin...
Repligen Corporation (“Repligen”) has signed a definitive agreement to acquire ARTeSYN BioSolutions (“ARTeSYN”). ARTeSYN is a manufacturer of innovative single-use solutions for the downstream bioprocessing industry. The Company is growing rapidly, led by the success...
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired TangenX Technology Corporation (“TangenX”) of Shrewsbury, MA, maker of the innovative single-use Sius™ line of tangential...
